Substance use, recovery and life insurance

The honest starting point

A history of substance use is assessed seriously. It is also not a permanent bar, and people with this history obtain life insurance regularly.

The most common outcome for someone in early recovery is a postponement, meaning the insurer wants more time before assessing. That is an instruction to return rather than a refusal, and it is worth reading it that way, because a lot of people take a postponement as a final answer and never come back.

For someone with several years of documented recovery, offers are realistic, often with a rating, and sometimes without one.

Time is the main variable

Insurers generally want a defined period since last use before they will assess a file, and how long depends on the substance and on the history.

What matters alongside the elapsed time is what fills it. A period of abstinence supported by evidence reads very differently from an unsupported assertion.

The kinds of evidence that carry weight: completion of a treatment program, continued engagement with follow-up or a support program, stable employment, and clean results where testing has been part of the picture. All of it appears in medical records.

Which substance, and how

Underwriters distinguish between substances, and the differences are real rather than moralistic.

Occasional past use of a substance many years ago, with no diagnosed disorder and no treatment, is a much smaller matter than dependence requiring treatment.

Injection use carries an additional consideration beyond the substance itself. It directs attention to whether screening for hepatitis and HIV has been done, and what it showed. Those are then assessed on their own terms, covered in hepatitis B and C and living with HIV. A clean screening record is a useful item in the file.

Stimulants raise cardiovascular questions, and where there has been heavy use, underwriters sometimes want cardiac investigation results.

Opioid agonist treatment

This deserves a clear statement because misunderstanding is common.

Opioid agonist therapy, including methadone and buprenorphine-naloxone, is an evidence-based treatment for opioid use disorder recognized across Canadian health systems. It is treatment, not continuing use, and underwriters that are current on this assess it accordingly.

What they look at is stability: how long you have been on the program, whether the dose has been steady, whether you attend consistently, whether there have been relapses, and how you are functioning generally.

Long-term stable participation with good follow-up can be assessed favourably. Recent commencement, or a pattern of interruptions, is more likely to result in a postponement.

Insurers vary noticeably here, and some are more current than others. It is a clear case for not accepting a single company’s answer.

Relapse

Relapse is a recognized part of many recovery trajectories and underwriters know that. It does not erase the history that came before it, and it does restart the clock on the period they want to see.

What an underwriter reads is the overall direction: whether the intervals between episodes are lengthening, whether treatment engagement has continued, and where things stand now.

What travels with it

Substance use and mental health conditions frequently appear together, and the combination is assessed as a whole. See depression and anxiety and, where relevant, bipolar disorder.

Alcohol often features alongside, and is assessed on the terms in alcohol history.

Any history of self-harm is assessed separately and seriously. See after a suicide attempt or self-harm.

While you wait

Where full underwriting is not yet available, coverage is still obtainable.

Group coverage through an employer generally involves no medical questions up to a set level and depends on employment rather than health.

Simplified issue products ask a short set of questions, usually time-bounded around treatment within a recent window, so dates determine availability.

Guaranteed issue asks nothing about health, at a smaller amount and with a waiting period at the start.

Putting something in place now and reapplying for fully underwritten coverage once the required period has passed is a sensible sequence. Do not cancel the interim policy until the replacement is in force.

Disclosing it

You have to, and it is difficult.

Medical records will reflect treatment, prescriptions will reflect agonist therapy, and insurers request records routinely on files like this. An omission found later converts a health question into a question about the application’s truthfulness, and that is what puts a claim at risk. See leaving something off the application.

A documented recovery is something an underwriter can assess. A concealed history is something they cannot, until it surfaces.

Applying

Work with someone who will place the file thoughtfully rather than submitting it blind. Have the dates, the treatment history, current medication including any agonist therapy, and the name of whoever is looking after you.

If the answer is a postponement, get the required period in writing and note the date.

The boundary

Nothing here is health information or guidance about substance use, treatment or recovery. This page describes how an insurance application is assessed. Everything else belongs with your doctor or your treatment team.